Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Neupro filed in Europe for advanced Parkinson's disease

July 5, 2006

Recent Abbott patent discloses novel vanilloid VR1 receptor antagonists

July 4, 2006

CHMP recommends Keppra monotherapy in epilepsy

July 4, 2006

NDA submission for Zensana Oral Spray

July 4, 2006

NDA submission for CIP-Tramadol ER

July 4, 2006

North American phase III study of Miraxion achieves target enrollment

July 4, 2006

Dosing under way in phase IIa nociceptive pain study of cannabinor

July 4, 2006

SBIR grant supports ArmaGen's development of AGT-140 for stroke

July 4, 2006

Antipsychotic, antidepressant agents disclosed in recent patents

July 3, 2006

Approvable letter for Fentora in breakthrough cancer pain

July 3, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.